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A review ofthe literature and an update that is in progress of a previous retrospective cohort mortality
studyofthestyrene-1,3-butadiene industryarediscussed. Thefollow-uphasnowbeenextendedfromApril 1,
1976, through December31, 1981, forplantB andDecember31, 1982, forplantA. The person-years atriskof
death have gone from 34,187 to 43,341 in plant A and from 19,742 to 26,314 in plant B. Among the death
certificates received to date, observeddeaths have increased in both plants, with increases in cancers ofthe
trachea, bronchusandlungand inlymphosarcomas, reticulosarcomas, andcancersoftheoveralllymphatic
and hematopoietic system.
Styrene-butadiene rubber (SBR), a copolymer of
styrene and 1,3-butadiene, is the most widely used syn-
thetic rubber in the world. The U.S. government fore-
saw shortages ofnatural rubber as aresult ofthe grow-
ing demands during World War II and financed con-
struction offifteen SBR plants, twobutylrubberplants,
sixteen 1,3-butadiene production facilities and five
styrene plants. Between 1946 and 1955 these plants
were sold to various private companies. In 1984, the
1,3-butadiene consumption inthe U.S. was estimated to
be about 3.24 billion pounds per year with at least 3
billion being used to make synthetic rubber (1). In the
National Institute for Occupational Safety and Health
(NIOSH) Criteria Document on Styrene, it was esti-
mated that the U.S. production of styrene in 1981 was
6.61 billion pounds per year, with approximately 0.44
billion pounds being used to manufacture SBR (2). The
number ofworkers employed in rubber and plastic pro-
duction was estimated to be a little over 9,000 (1). The
exactnumberofworkersemployedinSBRproductionis
unknown. Primarily, styrene is produced by de-
hydrogenating ethyl benzene, the reaction product of
benzene plus ethylene. A small portion is made from
ethylbenzene that is recovered directly from refinery
streams (3).
InJanuary 1976, two men who had been employed at
adjacent SBR production facilities in Port Neches, TX,
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died of leukemia. Simultaneous with these deaths an
article was published demonstrating an association be-
tween leukemia and employment in a large rubber pro-
duction facility (4). Based on these preliminary obser-
vations, a detailed environmental and epidemiological
study was conducted at these two SBR facilities to test
the hypothesis that employment in the SBR production
industry was associated with an increased risk of leu-
kemiaandwithanincreasedriskofothermalignanciesof
hematopoietic and lymphatic tissues.
The two plants included in this investigation began
operation in 1943. Plant A had employed atotal of3,494
persons, ofwhich 1,662 were white males with atleast 6
months of employment. Of the 1,662 white males, the
average length of employment was 9.48 years with an
average annual turnover rate of 7%. At the time of
initiation of the investigation there were 700 persons
employed.
Plant B was active from 1943 through 1947, then shut
down until 1950 when it was reopened. Personnel rec-
ords that date from 1950 were available on 2,015
workers. Ofthese 1,094werewhitemaleshavingatleast
6 months of employment, with an average length of
employment of10.78 years and an average annual turn-
over rate of 5.10%. An estimated 458 people were em-
ployed at the plant at the start of this investigation.
Processes andenvironmentalconditionschangedwith
time in these two plants. Originally, rubber was pro-
duced by a hot temperature, batch polymerization pro-
cess. The batch polymerization process was then con-
verted to acontinuous-feed operatingsystem. Finally, aLEMEN ET AL.
cold-temperature, continuous polymerization process
was developed to go along with the hot process. Ex-
tender oils were added to the process in the early 1950s
to ensure that the rubber product was not too hard for
futureprocessing. Inthefirstplant, apilotpolyethylene
operation was constructed in 1960, and it operated until
1965whenitwas discontinued. Ageneralmodernization
program of the production area was begun in 1967 at
both plants.
Styreneand 1,3-butadiene wereconsideredthetarget
chemicals for the investigation; however, benzene ex-
posure was also evaluated because ofits known associ-
ation with leukemia. Air samples were taken in both
plantsfromallareasandwerefoundtobewellwithinthe
existingOccupational Safetyand HealthAdministration
(OSHA) PELs (100 ppm styrene, 1000 ppm butadiene,
and 10 ppm benzene). Anecdotal information from dis-
cussions with plant A management personnel indicated
that benzene was not norhad everbeen directly used in
the production of SBR; therefore the observed con-
centrations might be explained by chance, general envi-
ronmental leaks, and styrene impurities.
The retrospective mortality portion of the inves-
tigation began onJanuary 1, 1943, in plant A andJanu-
ary 1, 1950, inplantBandwasconductedthroughMarch
31, 1976, foreachplant. Onlywhitemaleswith 6months
ofnonmanagement and nonadministrative employment
wereincluded intheanalysis. PlantAhadatotalof1,356
subjects alive (81.59%), 252 deceased (15.16%), and 54
lost to follow-up (3.25%). Plant B had 980 subjects alive
(89.58%), 80 deceased (7.31%), and 34 lost to follow-up.
Each death was coded by one nosologist, in accordance
with the International Lists of Diseases and Causes of
Death in effect at the time ofdeath, and then converted
into the seventh revision code for the purposes ofcom-
parison. A modified life-table technique (6,7) was used
to obtain the person-years at riskofdyingby5-yearage
groups, by 5-year calendar time periods, by duration of
work experience (exposure), and by time from initial
employment (latency) in the SBR production industry.
Person-years at risk ofdeath began accumulating at six
months after initial employment. For plant A, the total
person-years at risk was 34,186.63; for plant B, it was
19,741.95. The age, race, sex, calendartime, and cause-
specificmortalityratesofthe U.S. populationwerethen
applied to the appropriate stratum of person-years at
Table 1. Concentrations of styrene, 1,3-butadiene, and benzene
in plant A and plant B.
Concentration
Contaminant Samples Range, ppm Mean, ppm SD
Plant A
Styrene 55 0.03-6.46 0.94 1.23
1,3-Butadiene 41 0.11-4.17 1.24 1.20
Benzene 3 0.08-0.14 0.10 0.035
Plant B
Styrene 35 0.05- 12.3 1.99 3.00
1,3-Butadiene 47 0.34-174.0 13.50 29.90
Benzene 0
risk to generate the expected number of cause-specific
deathsinthe studypopulation. Thisexpectednumberof
deaths was then compared to the observed number of
deaths in the study population so that any standardized
mortalityratio(SMR) (expressed interms ofpercentage
without % symbol) could bedetermined. The magnitude
of the differences was evaluated by a two-sided test
statistic based on the Poisson distribution (with p <
0.05).
Theresultsofthisinvestigationfoundanonsignificant
excess ofdeath in the overall category oflymphatic and
hematopoietic tissues (ICD codes 200-205) in plant A (9
observed versus 5.79expected, SMR 155). Themajority
of this increase was accounted for by an approximate
doubling ofthe numberofdeaths due to leukemia. (ICD
Code 201) (5 observed versus 2.47 expected SMR 203).
No appreciable excesses were observed in these cat-
egories based on the mortality patterns of plant B
employees.
The general mortalitypattern forplant Aand plant B
showed that none of the major categories considered
were in excess based on the mortality experience ofthe
worker population from either plant. Many of these
categories, including total mortality, appear to have
substantial deficits in observed deaths, compared to the
expected number of deaths. Such observations have
been explained by the selection of healthy individuals
wheninitiallyemployedinthisindustryandotherphysi-
cally demanding industries (8,9). In other words, this
effectresults fromthe differences inthemortalityexpe-
rience ofa selected health worker population and in the
mortality experience of a general reference group like
the U.S. population, which is comprised of people in a
spectrum of health statuses.
When the records of the individuals identified with
leukemia (forthose who qualified and did notqualify for
inclusion in the study analysis) at plant A were re-
viewed, it was observed that most of these employees
had startedworkbeforethe end ofDecember 1945. The
datecorrespondstothetimewhenthebatchprocesswas
converted to a continuous feed operation and the war-
time production conditions were discontinued. Because
ofthese process changes, it was decided to evaluate the
mortalities of plant A white male employees who had
previously worked at least six months between the
beginning of January 1943, and the end of December
1945. This subgroup consisted of 600 workers with an
average length of employment of 11.89 years and an
average annual turnover rate of 7.0%. The vital status
forthis subcohort was: 365 subjects alive, 201 deceased,
and 34 (5.6%), for which the vital status was unknown.
Theexperienceofthissubcohortresultedintheaccumu-
lation of 17,086 person-years at risk of death.
The results showed deficits ofmortality for the cate-
gories of total mortality, all other cancers, and acci-
dents. Excesses in cause-specific mortality were ob-
servedintheoverall categoryofmalignantneoplasmsof
the lymphatic and hematopoietic tissues and its sub-
category, leukemia and aleukemia with associated
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SMRs of 212 and 278, respectively. The SMRs for the
subcategories of lymphatic and hematopoietic tissue
malignancies in this restricted subgroup are greater,
because this subgroup contained not only all qualifying
leukemia deaths, but also all ofthe remaininglymphatic
and hematopoietic tissue deaths that qualified for in-
clusion in the analysis. Since the evaluation ofthis sub-
cohort'smortalityexperiencewasaposteriori, theuseof
statistical tests may not appropriately assess chance
occurrence. However, if a one-sided test statistic was
used to evaluate the excesses observed in the sub-
categories of the lymphatic and hematopoietic tissue
malignancies, then the excess in the leukemia and aleu-
kemia category was significant with p < 0.05.
Thefindings ofthisstudyprovided limited supportfor
the suggestion that the production or manufacture of
SBR might be associated with an excess of lymphatic
and hematopoietic neoplasms, and continued follow-up
of these cohorts seemed warranted. In summary, no
statistically significant excesses in cause-specific mor-
tality were found in the overall populations at plant A,
plantB, ortherestrictedplantA, based onanevaluation
using a two-sided statistical test. There was a non-
statistically significant excess for neoplasms ofthe lym-
phatic and hematopoietic tissues found in the overall
plantApopulationandtherestrictedplantApopulation.
SincethecompletionoftheMeinhardt etal. report(5),
two animal inhalation bioassays have found 1,3-bu-
tadiene to be carcinogenic in rats (10) and in mice (11).
Additionally, the findings of McMichael et al. (4)
prompted a more detailed case-referent study of these
cancer deaths by Spirtas et al. (12); this evaluation
revealed an estimated relative risk of2.4 for fatal lym-
phatic and hematopoietic malignancies associated with
employment in the SBR production plant.
Monson and Nakano (13), examined the mortality
rates ofall members ofthe same localunion working for
onerubbercompanyinAkron, Ohio. Thestudyincluded
13,571 men who had worked during or after 1935 for at
least 5 years. Excesses of leukemia deaths were ob-
served for those men working in the tire and the pro-
cessing divisions with SMRs of 150 and 240, respec-
tively. The processing department included synthetic
rubber production. These results reinforce the possibil-
ity of an association between exposure to SBR produc-
tion and the development of lymphatic and hema-
topoietic malignancies.
Matanoski et al. (14) found no significant excesses in
cause-specific mortality in a study consisting of small
numbers of workers in the cohorts from 8 facilities,
which had relatively short latency periods among
workers thought to be exposed to SBR. The study had
limited ability to detect any significant excesses. In
addition, the environmental data were insufficient to
characterize and quantify chemical exposures by the
workers.
Downs et al. (15) reported on the mortality among a
cohort of 2,586 male workers who were employed at
least 6monthsbetween 1943 and 1979in a 1,3-butadiene
manufacturing plant supplying 1,3-butadiene to the two
SBR plants studied by Meinhardt et al.(5). These au-
thors compared the mortality patterns of the worker
cohort with both national U.S. mortality and with local
mortalitypatterns. Asinthe Meinhardt etal. report (5),
the overall total mortality was less than expected, with
anSMRof 80(p <0.05)forthecomparisonwiththeU.S.
mortality. For the all-cancer category the SMR was 84.
and corresponding comparisons with the local mortality
ratesresulted in SMRs of96 fortotal mortalityand 76 (p
< 0.05) for all cancer. The only significant excess of
death observed forthose inthe routinely exposed group
was forlymphosarcoma and reticulum cell sarcomawith
anSMRof235(8observedversus3.4expected,p < 0.05)
when compared with the national U.S. rates. Strokes
weresignificantlyincreased inthenonroutinelyexposed
group when compared with the local mortality rates
only. The authors emphasized the shortcomings of the
study to be (a) unreliable race designations, (b) lack of
work histories and industrial hygiene data, (c) an em-
ploymentperiod oflessthan5yearsforalmosthalfofthe
total cohort, (d) the possibility that the cohort was
incomplete, and a comparatively small sample size. On
the positive side, the authors point out that the study
involved one ofthe largestcohorts studiedto date. They
also affirmed that the power ofthe study was adequate
todetectadoublingofrisksformanycausesofdeathand
wassufficient todetect atriplingofriskformost causes.
In conclusion, the authors evaluated the role of 1,3-bu-
tadiene in the excess deaths noted and felt that further
follow-up and additional studies need careful attention.
The findings from each of the previously outlined
studies show similar observations of deaths. However,
theydonotprovide sufficientinsightintotherisksposed
to workers in the SBR production industry.
Currently the follow-up to the Meinhardt et al. study
(5) has been increased through December 31, 1982, for
plant A and December 31, 1981, for plant B. Crude
calculations suggest that the person-years at risks of
death have increased in plant A from 34,187 to 43,341
and in plant B from 19,742 to 26,314. In the subcohort,
the increase in person-years at risk of death has in-
creasedfrom 17,086to 19,582. Inaddition, there arenow
390 observed deaths in plant A, compared to 252 in the
first analysis, and 148 in plant B, compared to 80 at the
timeoffirstanalysis. ForthesubcohortofplantA, there
are now 294 observed deaths, compared to 201 at the
time ofthe last analysis. The mortality from malignant
neoplasms in plant A is now 77, compared to 45 in the
first analysis. In the subcohort ofplant A, the mortality
from malignant neoplasms increased from 39 to 61. For
plant B the mortality for malignant neoplasms has in-
creased from 11 to 29.
In plant A, mortality from trachea, bronchus, and
lung (ICD Codes 162-163) has increased from 16 deaths
to 34. The only other increases in SMRs were for lym-
phosarcoma and reticulosarcoma (ICD Code 200) from 3
deaths in the first analysis to 5 deaths currently. One
deathhas nowbeen observed for otherneoplasms ofthe
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lymphatic and hematopoietic tissues (ICD Codes 202,
203 and 205).
In the subcohort from plant A, maligant neoplasms of
the trachea, bronchus, and lung (ICD Codes 162-163)
have increased from 13 deaths to 24. The two additional
deaths from lymphosarcoma and reticulosarcoma in the
overall plant A cohort occurred in the subcohort. The
one new death from other neoplasms of the lymphatic
and hematopoietic tissues also occurred in this sub-
cohort. In the plant B cohort, malignant neoplasms of
the trachea, bronchus, and lung increased from 5 to 14.
The only other new death occurred in the category
leukemia and aleukemia (ICD Code 204), increasing the
observation from 1 to 2 deaths.
The continued analysis of the mortality occurring to
SBR production workers may never provide definitive
answers about the health effects associated with either
styrene or 1,3-butadiene because of the diffuse and
poorly defined nature of exposure in this industry. At
thepresenttime, itisnotclearfromthisstudywhethera
real leukemogenic risk is associated with SBR produc-
tion or whether the reported excesses in lymphatic and
hematopoietic malignancies are artifacts in the popu-
lations studied. However, since there are continuing
reports of additional cancers occurring to individuals
exposed to this industrial process and since the evalu-
ation of a mixed chemical exposure environment with
very low levels of exposure may provide evidence of
healthrisksnotdetectedinsingle-agentevaluations, the
continued evaluation ofworkers in this industry seems
warranted.
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